BCM
Boone Capital Management Portfolio holdings
AUM
$233M
This Quarter Return
+10.04%
1 Year Return
+15.17%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$428M
AUM Growth
+$428M
(+35%)
Cap. Flow
+$97.4M
Cap. Flow
% of AUM
22.74%
Top 10 Holdings %
Top 10 Hldgs %
66.3%
Holding
22
New
9
Increased
7
Reduced
4
Closed
1
Top Buys
| 1 |
CVS Health
CVS
|
$29M |
| 2 |
Amphastar Pharmaceuticals
AMPH
|
$24.7M |
| 3 |
Viatris
VTRS
|
$20.7M |
| 4 |
BERY
Berry Global Group, Inc.
BERY
|
$15.6M |
| 5 |
Xenon Pharmaceuticals
XENE
|
$11.8M |
Top Sells
| 1 |
Biogen
BIIB
|
$24.7M |
| 2 |
Molina Healthcare
MOH
|
$16.2M |
| 3 |
Cigna
CI
|
$12.1M |
| 4 |
Danaher
DHR
|
$4.78M |
| 5 |
IDEAYA Biosciences
IDYA
|
$1.38M |
Sector Composition
| 1 | Healthcare | 84.64% |
| 2 | Financials | 10.15% |
| 3 | Materials | 3.64% |
| 4 | Technology | 1.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Unum
UNM
$11.9B
| $43.5M | 10.15% | 961,661 +94,096 | +11% | +$4.26M |
|
2
Enovis
ENOV
$1.77B
| $31.5M | 7.36% | 562,739 +60,008 | +12% | +$3.36M |
|
3
Amgen
AMGN
$155B
| $29.2M | 6.82% | 101,508 +3,382 | +3% | +$974K |
|
|
4
CVS Health
CVS
$92.8B
| $29M | 6.77% | +367,370 | New | +$29M |
|
5
Globus Medical
GMED
$8.27B
| $28.2M | 6.59% | 529,825 +101,373 | +24% | +$5.4M |
|
|
6
Cigna
CI
$80.3B
| $26.8M | 6.27% | 89,640 -40,277 | -31% | -$12.1M |
|
|
7
Danaher
DHR
$147B
| $25.1M | 5.86% | 108,501 -20,662 | -16% | -$4.78M |
|
|
8
Amphastar Pharmaceuticals
AMPH
$1.42B
| $24.7M | 5.77% | +400,000 | New | +$24.7M |
|
|
9
Molina Healthcare
MOH
$9.8B
| $24.7M | 5.76% | 68,288 -44,890 | -40% | -$16.2M |
|
10
Baxter International
BAX
$12.7B
| $21.2M | 4.95% | 548,536 +79,131 | +17% | +$3.06M |
|
|
11
Viatris
VTRS
$12.3B
| $20.7M | 4.83% | +1,912,272 | New | +$20.7M |
|
|
12
IDEAYA Biosciences
IDYA
$2.15B
| $18.9M | 4.42% | 531,967 -38,715 | -7% | -$1.38M |
|
13
BridgeBio Pharma
BBIO
$9.89B
| $17.8M | 4.15% | 440,845 +127,464 | +41% | +$5.15M |
|
|
BERY
14
DELISTED
Berry Global Group, Inc.
BERY
| $15.6M | 3.64% | +231,456 | New | +$15.6M |
|
15
Quanterix
QTRX
$211M
| $15.5M | 3.63% | 568,544 | – | – |
|
16
Mirum Pharmaceuticals
MIRM
$3.71B
| $14.5M | 3.38% | 490,139 +100,348 | +26% | +$2.96M |
|
|
17
Xenon Pharmaceuticals
XENE
$2.98B
| $11.8M | 2.75% | +255,432 | New | +$11.8M |
|
18
Bio-Rad Laboratories Class A
BIO
$8.06B
| $11.5M | 2.69% | +35,713 | New | +$11.5M |
|
19
Orthofix Medical
OFIX
$592M
| $6.74M | 1.57% | +500,000 | New | +$6.74M |
|
20
Mesa Laboratories
MLAB
$373M
| $6.71M | 1.57% | +64,064 | New | +$6.71M |
|
21
Pennant Group
PNTG
$830M
| $4.59M | 1.07% | +329,660 | New | +$4.59M |
|
|
22
Biogen
BIIB
$19.4B
| – | – | -96,115 | Closed | -$24.7M |
|